Flora Growth Corp (FLGC)
1.32
+0.05
(+3.94%)
USD |
NASDAQ |
Sep 27, 16:00
1.31
-0.01
(-0.76%)
After-Hours: 20:00
Flora Growth Research and Development Expense (TTM): 0.142M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.142M |
| March 31, 2024 | 0.093M |
| December 31, 2023 | 0.062M |
| September 30, 2023 | 0.112M |
| June 30, 2023 | 0.183M |
| March 31, 2023 | 0.281M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.475M |
| September 30, 2022 | 0.467M |
| June 30, 2022 | 0.368M |
| March 31, 2022 | 0.318M |
| December 31, 2021 | 0.133M |
| September 30, 2021 | 0.066M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.062M
Minimum
Dec 2023
0.475M
Maximum
Dec 2022
0.225M
Average
0.1625M
Median
Research and Development Expense (TTM) Benchmarks
| MariMed Inc | -- |
| cbdMD Inc | 0.0329M |
| Bright Green Corp | -- |
| NovaBay Pharmaceuticals Inc | 0.043M |
| Palatin Technologies Inc | 25.13M |